Tag Archives: Christopher Rowley

Aldatu Licenses Technology from Harvard

One Step Closer to Affordable HIV DrugResistance Test

By Martha Henry

Harvard recently entered into a licensing agreement with Aldatu Biosciences for exclusive use of the PANDAA technology. Using PANDAA, Aldatu, a biotech start-up based at LabCentral in Cambridge, is developing a rapid HIV drug-resistance test for patients failing first-line antiretroviral therapy (ART).

Continue reading